OPTI — Crescent NV Income Statement
0.000.00%
- €16.75m
- €20.42m
- €12.55m
- 25
- 23
- 21
- 10
Annual income statement for Crescent NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 17.8 | 16.2 | 21.1 | 11.4 | 12.6 |
| Cost of Revenue | |||||
| Gross Profit | 5.37 | 5.51 | 7.41 | 3.38 | 5.09 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 22 | 21.1 | 23 | 18.5 | 15.8 |
| Operating Profit | -4.22 | -4.83 | -1.92 | -7.09 | -3.29 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.6 | -5.53 | -2.51 | -7.79 | -4.11 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.73 | -5.57 | -2.1 | -7.82 | -4.16 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -4.78 | -5.63 | -2.09 | -7.01 | -3.02 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.78 | -5.63 | -2.09 | -7.01 | -3.02 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.002 | -0.002 | 0 | -0.003 | -0.001 |